Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells

Journal of Experimental Medicine

Volumn 189, Issue 3, 1999, Pages 501-508

  Park, Steven T ^a   Nolan, Garry P ^b   Sun, Xiao Hong ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Kaplan Cancer Center   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; E2A; Growth inhibition; Leukemogenesis; Tal1

Indexed keywords

HYBRID PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; GENE INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN DNA INTERACTION; T CELL LEUKEMIA;

APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASPASES; CELL DIVISION; CULTURE MEDIA, SERUM-FREE; DNA-BINDING PROTEINS; GROWTH INHIBITORS; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL, ACUTE; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; TCF TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 0033081234     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.189.3.501     Document Type: Article

References (34)

1. Begley, C.G., P.D. Aplan, S.M. Denning, B.F. Haynes, T.A. Waldmann, and I.R. Kirsch. 1989. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. Proc. Natl Acad. Sci. USA. 86:10128-10132.
2. Chen, Q., J.T. Cheng, L.H. Tasi, N. Schneider, G. Buchanan, A. Carroll, W. Crist, B. Ozanne, M.J. Siciliano, and R. Baer. 1990. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein. EMBO (Eur. Mol. Biol. Organ.) J. 9:415-424.
3. Brown, L., J.T. Cheng, Q. Chen, M.J. Siciliano, W. Crist, G. Buchanan, and R. Baer. 1990. Site-specific recombination of the tal-1 gene is a common occurrence in human cell leukemia. EMBO (Eur. Mol. Biol. Organ.) J. 9:3343-3351.
4. Carroll, A.J., W.M. Crist, M.P. Link, M.D. Amylon, D.J. Pullen, A.M. Ragab, G.R. Buchanan, R.S. Wimmer, and R.J. Vietti. 1990. The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 76:1220-1224.
5. Bash, R.O., S. Hall, C.F. Timmons, W.M. Crist, M. AmyIon, R.G. Smith, and R. Baer. 1995. Does activation of the TAL gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A Pediatric Oncology Group study. Blood. 86:666-676.
6. Pulford, K., N. Lecointe, K. Leroy-Viard, M. Jones, D. Mathieu-Mahul, and D.Y. Mason. 1995. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood. 85:675-684.
7. Kallianpur, A.R., J.E. Jordan, and S.J. Brandt. 1994. The SCL/TAL-1 gene is expressed in progenitors of both the hematopoietic and vascular systems during embryogenesis. Blood. 83:1200-1208.
8. Shivdasani, R.A, E.L. Mayer, and S.H. Orkin. 1995. Absence of blood formation in mice lacking the T cell leukemia oncoprotein tal-1/SCL. Nature. 373:432-434.
9. Porcher, C., W. Swat, K. Rockwell, Y. Fujiwara, F.W. Alt, and S.H. Orkin. 1996. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 86:47-57.
10. Visvader, J.E., Y. Fujiwara, and S.H. Orkin. 1998. Unsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular development. Genes Dev. 12:473-479.
11. Weintraub, H., R. Davis, S. Tapscott, M. Thayer, M. Krause, R. Benezra, T.K. Blackwell, D. Turner, R. Rupp, S. Hollenberg, et al. 1991. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 251: 761-766.
12. Murre, C., G. Bain, M.A. van Dijk, I. Engel, B.A. Furnari, M.E. Massari, J.R. Matthews, M.W. Quong, R.R. Rivera, and M.H. Stuiver. 1994. Structure and function of helix-loop-helix proteins. Biochim. Biophys. Acta. 1218:129-135.
13. Murre, C., P.S. McCaw, H. Vaessin, M. Caudy, L.Y. Jan, Y.N. Jan, C.V. Cabrera, J.N. Buskin, S.D. Hauschka, A.B. Lassar, et al. 1989. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell. 58:537-544.
14. Hsu, H.L., J.T. Cheng, Q. Chen, and R. Baer. 1991. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol. 11:3037-3042.
15. Cheng, J.T., H.L. Hsu, L.Y. Hwang, and R. Baer. 1993. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues. Oncogene. 8:677-683.
16. Condorelli, G., L. Vitelli, M. Valtieri, I. Marta, E. Montesoro, V. Lulli, R. Baer, and C. Peschle. 1995. Coordinate expression and developmental role of Id2 protein and TAL1/ E2A heterodimer in erythroid progenitor differentiation. Blood. 86:164-175.
17. Condorelli, G.L., F. Facchiano, M. Valtieri, E. Proietti, L. Vitelli, V. Lulli, K. Huebner, C. Peschle, and C.M. Croce. 1996. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice. Cancer Res. 56:5113-5119.
18. Kelliher, M.A., D.C. Seldin, and P. Leder. 1996. Tal-1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIa. EMBO (Eur. Mol. Biol. Organ.) J. 15:5160-5166.
19. Hsu, H.L., I. Wadman, J.T. Tsan, and R. Baer. 1994. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc. Natl. Acad. Sci. USA. 91:5947-5951.
20. Doyle, K., Y. Zhang, R. Baer, and M. Bina. 1994. Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins. J. Biol. Chem. 269:12099-12105.
21. Park, S.T., and X.-H. Sun. 1998. The Tall oncoprotein inhibits E47-mediated transcription: mechanism of inhibition. J. Biol. Chem. 273:7030-7037.
22. Bain, G., I. Engel, E.C. Robanus Maandag, H.P. te Riele, J.R. Voland, L.L. Sharp, J. Chun, B. Huey, D. Pinkel, and C. Murre. 1997. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:4782-4791.
23. Yan, W., A.Z. Young, V.C. Soares, R. Kelley, R. Benezra, and Y. Zhuang. 1997. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:7317-7327.
24. Pear, W.S., J.P. Miller, L. Xu, J.C. Pui, B. Soffer, R.C. Quackenbush, A.M. Pendergast, R. Bronson, J.C. Aster, M.L. Scott, and D. Baltimore. 1998. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 92:3780-3792.
25. Pear, W.S., G.P. Nolan, M.L. Scott, and D. Baltimore. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA. 90:8392-8396.
26. Hitoshi, Y., J. Lorens, S.I. Kitada, J. Fisher, M. LaBarge, H.Z. Ring, U. Francke, J.C. Reed, S. Kinoshita, and G.P. Nolan. 1998. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells. Immunity. 8:461-471.
27. Schreiber, E., P. Matthias, M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17:6419.
28. Mahajan, M., S.T. Park, and X.-H. Sun. 1996. Association of a novel GTP-binding protein, DRG, with TAL oncogenic proteins. Oncogene. 12:2343-2350.
29. Lissy, N.A., F. Van Dyk, M. Becker-Hapak, A. Vocero-Akbani, J.H. Mendler, and S.F. Dowdy. 1998. TCR antigen-induced cell death occurs from a late G1 phase cell cycle check point. Immunity. 8:57-66.
30. Gillis, S., and J. Watson. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152:1709-1719.
31. Ueda, N., and S. Shah. 1994. Apoptosis. J. Lab. Clin. Med. 124:169-177.
32. Dolle, R.E., D. Hoyer, C.V. Prasad, S.J. Schmidt, C.T. Helaszek, R.E. Miller, and M.A. Ator. 1994. P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy) methyl ketones as potent time-dependent inhibitors of interleukin-1 beta converting enzyme. J. Med. Chem. 37:3863-3866.
33. Prabhu, S., A. Ignatova, S.T. Park, and X.-H. Sun. 1997. Regulation of the expression of cyclin-dependent kinase inhibitor, p21, by E2A and Id proteins. Mol. Cell. Biol. 17: 5888-5896.
34. Aplan, P.D., C.A. Jones, D.S. Chervinsky, X. Zhao, M. Ellsworth, C. Wu, E.A. McGuire, and K.W. Gross. 1997. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T-cell malignancies in transgenic mice. EMBO (Eur. Mol. Biol. Organ.) J. 16:2408-2419.